Sympathetic system activity in obesity and metabolic syndrome
- PMID: 17148737
- DOI: 10.1196/annals.1367.010
Sympathetic system activity in obesity and metabolic syndrome
Abstract
Obesity is a very common disease worldwide, resulting from a disturbance in the energy balance. The metabolic syndrome is also a cluster of abnormalities with basic characteristics being insulin resistance and visceral obesity. The major concerns of obesity and metabolic syndrome are the comorbidities, such as type 2 diabetes, cardiovascular disease, stroke, and certain types of cancers. Sympathetic nervous system (SNS) activity is associated with both energy balance and metabolic syndrome. Sympathomimetic medications decrease food intake, increase resting metabolic rate (RMR), and thermogenic responses, whereas blockage of the SNS exerts opposite effects. The contribution of the SNS to the daily energy expenditure, however, is small ( approximately 5%) in normal subjects consuming a weight maintenance diet. Fasting suppresses, whereas meal ingestion induces SNS activity. Most of the data agree that obesity is characterized by SNS predominance in the basal state and reduced SNS responsiveness after various sympathetic stimuli. Weight loss reduces SNS overactivity in obesity. Metabolic syndrome is characterized by enhanced SNS activity. Most of the indices used for the assessment of its activity are better associated with visceral fat than with total fat mass. Visceral fat is prone to lipolysis: this effect is mediated by catecholamine action on the sensitive beta(3)-adrenoceptors found in the intraabdominal fat. In addition, central fat distribution is associated with disturbances in the hypothalamo-pituitary-adrenal axis, suggesting that a disturbed axis may be implicated in the development of the metabolic syndrome. Furthermore, SNS activity induces a proinflammatory state by IL-6 production, which in turn results in an acute phase response. The increased levels of inflammatory markers seen in the metabolic syndrome may be elicited, at least in part, by SNS overactivity. Intervention studies showed that the disturbances of the autonomic nervous system seen in the metabolic syndrome are reversible.
Similar articles
-
What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.Exp Clin Endocrinol Diabetes. 1998;106 Suppl 2:29-34. doi: 10.1055/s-0029-1212034. Exp Clin Endocrinol Diabetes. 1998. PMID: 9792479 Review.
-
The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.Med Hypotheses. 2006;67(4):879-91. doi: 10.1016/j.mehy.2006.04.008. Epub 2006 Jun 15. Med Hypotheses. 2006. PMID: 16781084
-
The selfish brain: competition for energy resources.Prog Brain Res. 2006;153:129-40. doi: 10.1016/S0079-6123(06)53007-9. Prog Brain Res. 2006. PMID: 16876572 Review.
-
Cardiac autonomic nervous system activity in obesity.Pediatr Endocrinol Rev. 2004 Aug;1 Suppl 3:476-83. Pediatr Endocrinol Rev. 2004. PMID: 16444178 Review.
-
Sympathetic-leptin relationship in obesity: effect of weight loss.Metabolism. 2008 Apr;57(4):555-62. doi: 10.1016/j.metabol.2007.11.020. Metabolism. 2008. PMID: 18328360 Clinical Trial.
Cited by
-
Salivary alpha amylase diurnal pattern and stress response are associated with body mass index in low-income preschool-aged children.Psychoneuroendocrinology. 2015 Mar;53:40-8. doi: 10.1016/j.psyneuen.2014.12.011. Epub 2014 Dec 22. Psychoneuroendocrinology. 2015. PMID: 25588701 Free PMC article.
-
Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioning.J Appl Physiol (1985). 2011 Mar;110(3):746-55. doi: 10.1152/japplphysiol.00293.2010. Epub 2010 Nov 25. J Appl Physiol (1985). 2011. PMID: 21109598 Free PMC article.
-
The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol.Int J Obes (Lond). 2015 May;39(5):747-54. doi: 10.1038/ijo.2014.208. Epub 2014 Dec 15. Int J Obes (Lond). 2015. PMID: 25504041
-
Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective.J Neuroimmune Pharmacol. 2013 Mar;8(1):212-26. doi: 10.1007/s11481-012-9432-6. Epub 2013 Jan 18. J Neuroimmune Pharmacol. 2013. PMID: 23329173 Review.
-
Central sympathetic overactivity: maladies and mechanisms.Auton Neurosci. 2009 Jun 15;148(1-2):5-15. doi: 10.1016/j.autneu.2009.02.003. Epub 2009 Mar 6. Auton Neurosci. 2009. PMID: 19268634 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical